Related Experiment Video
Updated: Jun 18, 2026

07:51
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Hazard Ratio to Life Expectancy: Gompertz-Makeham Validation of Emerging Risk Factors Collaboration Cardiometabolic
Journal of Insurance Medicine (New York, N.Y.)
|June 17, 2026
Summary
This study validates cardiometabolic life years lost (LYL) tables using a Gompertz-Makeham model. The validated model offers accurate, reproducible LYL estimates for insurance and medico-legal use.
Area of Science:
- Epidemiology
- Biostatistics
- Actuarial Science
Background:
- Emerging Risk Factors Collaboration (ERFC) provides high-risk cardiometabolic life years lost (LYL) tables.
- Existing tables require validation for broader application in insurance and medico-legal contexts.
- Gompertz-Makeham models offer a flexible framework for survival analysis.
Purpose of the Study:
- To validate the ERFC high-risk LYL tables.
- To calibrate a Gompertz-Makeham model using hazard ratios (HR).
- To establish a reproducible framework for actuarial risk assessment and life expectancy projections.
Main Methods:
- Utilized data from 91 cohorts (689,300 participants) with high hazard ratios (HR≥5).
- Benchmarked ERFC LYL tables against Irish Life Tables No. 17.
- Applied Gompertz-Makeham modeling to generate survival curves and calculate LYL based on baseline risk differentials (ages 40-85).
- Assessed model performance using mean absolute error (MAE).
Main Results:
- The Gompertz-Makeham model accurately reproduced ERFC high-risk LYL estimates.
- Achieved low mean absolute error (MAE) for males (1.21 years) and females (1.16 years) across ages 40-85.
- Preserved the empirical survival curve without requiring disease-specific adjustments.
- Life years lost at age 40 were estimated at 20-22 years, and at age 75, 5-6 years.
Conclusions:
- The hazard ratio-calibrated Gompertz-Makeham model provides aetiology-independent LYL estimates with high accuracy (1-2 years MAE).
- This approach extends existing disability models to accommodate multimorbidity.
- Offers a robust and reproducible framework for actuarial risk assessment and forensic life expectancy reports.
Related Concept Videos
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
Hazard Rate
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
Life Tables
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
